Microbiota Therapeutics Could Become Strong Ally in IBD Tx :

Novel therapeutics could offer clinicians an additional tool in developing their patient treatment plans, particularly for those with no response or resistance to existing therapies.

Related Keywords

New York , United States , R Balfour Sartor , , Icahn School Of Medicine At Mount Sinai , University Of North Carolina At Chapel Hill , Ari Grinspan , Icahn School , Mount Sinai , New York City , Medscape Medical , Lancet Gastroenterology , Next Step , Gastrointestinal Biology , North Carolina , Chapel Hill , Inflammatory Bowel Disease Ibd , Microbiome , Microbiota , Fecal Transplantation , Stool Transplant , Ecal Bacteriotherapy , Fecal Microbiota Transplantation , Mt Faecal Transplant Transplantation Bacteriotherapy Microbiota , C Diff Infection , Clostridium Difficile Infection , Lostridium Difficile Associated Disease ,